Document is current
Any future updates will be listed below
-
Authors
Kaulen, Leon D. https://orcid.org/0000-0002-5937-3376
Denisova, Evgeniya https://orcid.org/0000-0001-6258-8055
Hinz, Felix
Hai, Ling https://orcid.org/0000-0001-8719-2727
Friedel, Dennis
Henegariu, Octavian https://orcid.org/0000-0002-8971-1049
Hoffmann, Dirk C. https://orcid.org/0000-0003-1370-1933
Ito, Jakob
Kourtesakis, Alexandros https://orcid.org/0000-0002-7894-9131
Lehnert, Pascal
Doubrovinskaia, Sofia https://orcid.org/0000-0003-4470-8396
Karschnia, Philipp https://orcid.org/0000-0002-1254-5310
von Baumgarten, Louisa https://orcid.org/0000-0002-6634-0927
Kessler, Tobias https://orcid.org/0000-0001-8350-7074
Baehring, Joachim M. https://orcid.org/0000-0001-7755-6793
Brors, Benedikt https://orcid.org/0000-0001-5940-3101
Sahm, Felix https://orcid.org/0000-0001-5441-1962
Wick, Wolfgang https://orcid.org/0000-0002-6171-634X
-
Funding
Funding for this research was provided by:
Universitätsklinikum Heidelberg
- License Information
-
More Information
Article History
Received: 28 May 2023
Revised: 10 July 2023
Accepted: 11 July 2023
First Online: 26 July 2023
Declarations
:
: Dr. Kaulen reports no disclosures. Dr. Denisova reports no disclosures. Dr. Hinz reports no disclosures. Ms. Hai reports no disclosures. Mr. Friedel reports no disclosures. Dr. Henegariu reports no disclosures. Mr. Hoffmann reports no disclosures. Mr. Ito reports no disclosures. Mr. Kourtesakis reports no disclosures. Mr. Lehnert reports no disclosures. Dr. Doubrovinskaia reports no disclosures. Dr. Karschnia reports no disclosures. Dr. von Baumgarten reports no disclosures. Dr. Kessler reports no disclosures. Dr. Baehring reports no disclosures. Dr. Brors reports no disclosures. Dr. Sahm reports honoraria from Illumina, Agilent and Bayer, patents on methylation-based classification managed by DKFZ, and being cofounder and shareholder of Heidelberg Epignostix GmbH. Dr. Wick reports support for clinical trials from Apogenix, Pfizer, Roche and Vaximm as well as honoraria for advice from Astra Zeneca, Enterome, MSD, Roche, Servier and Vaximm paid to the Medical Faculty.
